CCNE1 and cancer: There is an ever-increasing body of work linking the quiescent nature of cancer stem cells with drug resistance, including a recent report in IBC, which showed that the cancer stem cell population (CD44hi, CD24low cells) expresses high levels of cyclin E, and combined targeting of CDK2 enhances response to chemotherapy [35].